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Editorial on the Research Topic
Mapping Psychopathology with fMRI and Effective Connectivity Analysis
Distributed networks of interacting brain systems—rather than a single area—are usually involved
in the execution of a specific cognitive task. Recent advances in neuroimaging techniques now
allow us to see how these interacting brain regions are integrated and cooperate with each other
to prosecute cognitive operations (Razi and Friston, 2016). Brain connectivity analyses based
on electroencephalography (EEG), magnetoencephalography (MEG), and functional magnetic
resonance imaging (fMRI) signals characterize neuronal responses in terms of how brain activity is
induced by external stimuli and propagates among distributed brain regions, and thus may help
answer key questions about functional brain architectures. The insights that brain connectivity
analyses offer is also crucial for us to elucidate the neurobiological correlates underlying many
neuropsychiatric disorders.
Functional connectivity and effective connectivity are generally used to measure functional
integration in neuroimaging. The former examines (undirected) statistical dependencies (e.g.,
temporal correlations) between brain regions and has been extensively studied to characterize brain
networks at rest. However, understanding the precise mechanisms mediating cognitive processes
depend on directed information flow within brain networks. Thus, the current research topic
focuses on mapping psychopathology with (directed) effective connectivity analysis, which models
causal interactions among brain regions. We attempt to further improve current understanding
of the neural mechanisms of major neuropsychiatric disorders by exploring how signals are
transmitted differently from one region to another in healthy controls and patients. This
comparisonmay help explain the pathophysiology and psychopathology seen in these disorders—at
a network and possibly synaptic level.
In this research topic, we invited world-renowned experts to present their recent work that have
utilized various models of directed connectivity; including psychophysiological interactions (PPI),
Granger causality (GC), and dynamic causal modeling (DCM) to investigate directed connectivity
in healthy subjects and patients with neuropsychiatric disorders. The papers in this research topic
further our knowledge of the neurobiological mechanisms underlying neurological and psychiatric
disorders. We will see that young people with OCD exhibit increased dorsal anterior cingulate
cortex (dACC) modulatory effects during the performance of working memory tasks (Diwadkar
et al.). There is also new evidence suggesting that neurodegenerative disorders like Parkinson’s
disease (Yan et al.) and Huntington’s disease (Minkova et al.) are characterized by impaired causal
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interactions of the motor control system (Dowlati et al.) speaking
to the interesting notion that age-dependent neural mechanisms
may be important for understanding aberrant belief states
associated with psychopathology. Interestingly, abnormalities in
brain effective connectivity are also seen clearly in resting state
in subjects with schizophrenia (Cui et al.), smoking addiction
(Tang et al.), idiopathic generalized epilepsy (Wei et al.) and
cocaine users (Ray et al.). In addition, it is exciting to see that
effective connectivity analysis may furnish a new framework to
understand fatigue and depression (Stephan et al.). We believe
these findings have the potential to invigorate and advance
our understanding of the neurobiological mechanisms of major
neuropsychiatric disorders, thus improving the prevention,
diagnosis and treatment of these disorders.
Looking into the future, we anticipate a shift toward new
methods that can measure effective connectivity among specific
cell types (e.g., lamina-specific connectivity). For example,
methods that use detailed biophysical modeling based on
canonical microcircuits and neural mass models for functional
MRI data (Friston et al., in press) or that combine other
modalities—like optogenetics—with fMRI (Bernal-Casas et al.,
2017). These new methods will be very useful within the context
of detecting early and selective abnormalities in specific cell types
in various forms of dementia. For example, frontotemporal lobar
degeneration (FTLD) has been previously shown to selectively
target Von Economo neurons in fronto-insular regions (Seeley
et al., 2006) and that pathogenic huntingtin protein selectively
targets striatal spiny projection neurons (Ehrlich, 2012). More
detailed and informed models of effective connectivity may also
be very useful for furthering recent (and exciting) developments
in understanding compensatory mechanisms in presymptomatic
neurodegeneration that could potentially translate to the
discovery of reliable neuronal biomarkers of disease progression
(Klöppel et al., 2015). We envisage that computational modeling
of dementia will usher a new era of functional integration
research, by increasing our understanding of mechanisms by
which molecular lesions engender specific meso and macro scale
neural network damage that maps onto specific phenotypes
(Gilson et al., 2016).
A complete understanding of complex (many-to-many)
protein-network-phenotype mappings will be crucial for
the early diagnosis and development of interventional
therapies for slowing and preventing dementia. In psychiatry,
computational modeling has already given a birth to the
new field of computational psychiatry that constitutes a new
paradigm for translational research and clinical decision
making (Montague et al., 2012; Friston et al., 2014). The
potential for developing new treatments for psychiatric
illnesses that go beyond addressing symptoms is promising and
any computational modeling that can precisely characterize
aberrant connectivity may play a central role in predicting
an individual’s clinical trajectory (Stephan and Mathys, 2014;
Friston, 2016).
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